Skip to main content Help with accessibility Skip to main navigation

Cenobamate

Indication

Treating focal onset seizures in epilepsy (NICE TA753)

NICE TA753 - Cenobamate for treating focal onset seizures in epilepsy

Red

Brand:

Nice TA:

753

Commissioning responsibility:

CCG

PbR excluded:

No

BNF chapter:
Central nervous system

Background

1.1 Cenobamate is recommended as an option for treating focal onset seizures with or without secondary generalised seizures in adults with drug-resistant epilepsy that has not been adequately controlled with at least 2 antiseizure medicines. It is recommended only if:

  • it is used as an add-on treatment, after at least 1 other add-on treatment has not controlled seizures, and

  • treatment is started in a tertiary epilepsy service.

Recommendation

LSCMMG Recommendation:

Red

Reason for decision:

Specialist medicine

Supporting documents:

Decisions of Lancashire local decision making groups

Red
Red
Red
Red
Red
Red
Red
Red
What do the colours mean?

Last Updated: 18 - Jan - 2022